4D Molecular Therapeutics
4DMT develops gene therapies and sustained-release biologics for retinal and pulmonary diseases.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 12Latest story
November 2026
September 2026
August 2026
June 2026
4DMT develops gene therapies and sustained-release biologics for retinal and pulmonary diseases.
November 2026
September 2026
August 2026
June 2026